English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
e
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
Login
Videos
[2217]
News
[4959]
Articles
[119]
Editorials
[4]
Conferences
[153]
e
learning
[8]
ASCO 2022: Latest developments in mHSPC and mCRPC
Prof Heather Payne, Prof Kim Chi, Prof Laura-Maria Krabbe and Prof Kurt Miller
6 Jun 2022
COSMIC-021: Cabozantinib plus atezolizumab gives encouraging clinical activity...
Dr Sumanta K. Pal - City of Hope Comprehensive Cancer Center, Duarte, USA
5 Jun 2022
Safety follow-up of the randomized, phase 3 study DESTINY-Breast03
Dr Erika Hamilton - Sarah Cannon Research Institute, Tennessee, USA
5 Jun 2022
ASCO 2022: Latest in EGFR positive NSCLC
Prof Benjamin Besse, Dr Anna Minchom, Dr Antonio Passaro and Dr Enriqueta Felip
5 Jun 2022
Panitumumab plus mFOLFOX6 improves OS for RAS wild-type left sided mCRC
Dr Takayuki Yoshino - National Cancer Center Hospital East, Kashiwa, Japan
5 Jun 2022
Comment: Phase III assessment of topotecan, cyclophosphamide and high-dose...
Dr Julie Gralow- Chief Medical Officer, ASCO
5 Jun 2022
Phase 3 study shows HER2 therapy clinically meaningful for metastatic breast...
Shanu Modi- Memorial Sloan Ketting Cancer Center, Manhattan, USA
5 Jun 2022
High-dose ifosfamide standard of care for recurrent and primary refractory...
Dr Martin McCabe - University of Manchester, Manchester, England
5 Jun 2022
Lenalidomide, bortezomib, and dexamethasone ASCT to progress for NDMM: Phase 3...
Dr Paul Richardson - Dana Farber Cancer Institute, Boston, USA
5 Jun 2022
Single-agent PD-1 blockade as curative-intent treatment in mismatch repair...
Dr Andrea Cercek - Memorial Sloan Kettering Cancer Centre, Manhattan, New York
5 Jun 2022
Latest in testing and diagnostics in exon 20 NSCLC
Dr Antonio Passaro and Prof Paul Hofman
4 Jun 2022
Review: Best options in localised prostate cancer
Prof Eleni Efstathiou, Prof Oliver Sartor, Prof Kurt Miller and Prof Karim...
4 Jun 2022
<
1
...
32
33
34
35
36
...
185
>
More from
e
cancer